Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
43.82
+0.17 (0.39%)
Nov 21, 2024, 12:19 PM EST - Market open
Avidity Biosciences Employees
Avidity Biosciences had 253 employees as of December 31, 2023. The number of employees increased by 67 or 36.02% compared to the previous year.
Employees
253
Change (1Y)
67
Growth (1Y)
36.02%
Revenue / Employee
$39,988
Profits / Employee
-$1,108,648
Market Cap
5.23B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 253 | 67 | 36.02% |
Dec 31, 2022 | 186 | 61 | 48.80% |
Dec 31, 2021 | 125 | 54 | 76.06% |
Dec 31, 2020 | 71 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Stevanato Group | 5,634 |
Waystar Holding | 1,400 |
Inspire Medical Systems | 1,011 |
Ionis Pharmaceuticals | 927 |
Lantheus Holdings | 834 |
PROCEPT BioRobotics | 626 |
ADMA Biologics | 624 |
Corcept Therapeutics | 352 |
RNA News
- 9 days ago - Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations - PRNewsWire
- 13 days ago - Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights - PRNewsWire
- 21 days ago - Avidity Biosciences to Host Investor and Analyst Event Focused on Precision Cardiology Candidates and First Look at Next-Generation Technology Innovations on November 12, 2024 - PRNewsWire
- 4 weeks ago - Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 2 months ago - Avidity Biosciences to Participate in Upcoming Investor Conference - PRNewsWire
- 2 months ago - Goldman Sachs Bullish On Avidity Biosciences, Cites Scalable RNA Therapeutics Platform For Rare Diseases - Benzinga
- 2 months ago - Avidity Biosciences Joins Patient and Advocacy Communities in Raising Awareness During National Muscular Dystrophy Awareness Month - PRNewsWire
- 3 months ago - Avidity Biosciences to Participate in Upcoming Investor Conferences - PRNewsWire